Kestrel Investment Management Corp Myriad Genetics Inc Transaction History

Kestrel Investment Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$20.93 - $35.1 $4.81 Million - $8.07 Million	-229,925 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $43,056 - $91,806	-1,950 Reduced 0.84%	229,925 $6.58 Million
Q2 2019 Aug 13, 2019	SELL	$22.67 - $35.0 $24,937 - $38,500	-1,100 Reduced 0.47%	231,875 $6.44 Million
Q1 2019 May 13, 2019	BUY	$26.93 - $34.7 $6.27 Million - $8.08 Million	232,975 New	232,975 $7.74 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Kestrel Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Kestrel Investment Management Corp with notifications on news.